American Headache Society Annual Scientific Meeting (AHS)

Shorts

AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
1:13
AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
5 months ago
by
Amaal J. Starling, MD(+1 more)

Latest Content

Survey data revealed 36% of patients with migraine with prescription medications were using opioids in acute management, though data also reinforced that receiving a diagnosis of migraine or chronic migraine was associated with a significantly decreased likelihood of opioid use.